537 related articles for article (PubMed ID: 27475241)
1. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
[TBL] [Abstract][Full Text] [Related]
3. 5-alpha reductase inhibitors and erectile dysfunction: the connection.
Erdemir F; Harbin A; Hellstrom WJ
J Sex Med; 2008 Dec; 5(12):2917-24. PubMed ID: 19090946
[TBL] [Abstract][Full Text] [Related]
4. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Lee S; Lee YB; Choe SJ; Lee WS
Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
[TBL] [Abstract][Full Text] [Related]
5. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
Coskuner ER; Ozkan B; Culha MG
Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
[TBL] [Abstract][Full Text] [Related]
6. Why Odds Ratios Can Be Tricky Statistics: The Case of Finasteride, Dutasteride, and Sexual Dysfunction.
Andrade C
J Clin Psychiatry; 2018 Nov; 79(6):. PubMed ID: 30549493
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia.
Zhou Z; Cui Y; Wu J; Ding R; Cai T; Gao Z
BMC Urol; 2019 Mar; 19(1):17. PubMed ID: 30871552
[TBL] [Abstract][Full Text] [Related]
8. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
[TBL] [Abstract][Full Text] [Related]
9. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
Fertig RM; Gamret AC; Darwin E; Gaudi S
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
[TBL] [Abstract][Full Text] [Related]
10. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
[TBL] [Abstract][Full Text] [Related]
11. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis.
Zhang JJ; Shi X; Wu T; Zhang MD; Tang J; Yin GM; Long Z; He LY; Qi L; Wang L
Asian J Androl; 2022; 24(4):390-397. PubMed ID: 34747724
[TBL] [Abstract][Full Text] [Related]
12. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Gacci M; Ficarra V; Sebastianelli A; Corona G; Serni S; Shariat SF; Maggi M; Zattoni F; Carini M; Novara G
J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
[TBL] [Abstract][Full Text] [Related]
13. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
Gur S; Kadowitz PJ; Hellstrom WJ
Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718
[TBL] [Abstract][Full Text] [Related]
15. 5α-Reductase inhibitors in androgenetic alopecia.
Yim E; Nole KL; Tosti A
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):493-8. PubMed ID: 25268732
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
Corona G; Rastrelli G; Maseroli E; Balercia G; Sforza A; Forti G; Mannucci E; Maggi M
J Endocrinol Invest; 2012 Nov; 35(10):915-20. PubMed ID: 22777612
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.
Kim JH; Baek MJ; Sun HY; Lee B; Li S; Khandwala Y; Del Giudice F; Chung BI
PLoS One; 2018; 13(10):e0203479. PubMed ID: 30281615
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
19. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
Said MA; Mehta A
Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
[TBL] [Abstract][Full Text] [Related]
20. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Arias-Santiago S; Camacho-Martínez FM
Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
